Patienten mit Diabetes und Depression stellen eine Herausforderung für die hausärztliche
Praxis dar. Depressive Diabetiker haben bezüglich Morbidität und Mortalität eine deutlich
schlechtere Prognose als nicht depressive Diabetiker. Obwohl es effektive Behandlungsmöglichkeiten
gibt, werden viele depressive Diabetiker in der klinischen Routine nicht erkannt.
Dabei ist die Diagnose relativ einfach mithilfe eines strukturierten Gespräches oder
unkompliziert auszufüllender Fragebögen zu stellen. Das Ansprechen der Problematik
und der Besuch einer Diabetesschulung können ein erster Schritt zur Behandlung der
Depression sein. Bei der medikamentösen Therapie der Depression müssen die möglichen
Neben-/Wechselwirkungen mit der Diabetestherapie beachtet werden.
Patients with diabetes and depression represent a major challenge for the general
practitioner. With regard to mortality and morbidity, diabetic patients with depression
have a markedly poorer prognosis than those without depression. Although effective
treatment options are available, many diabetic patients with depression are not recognized
in the clinical routine in spite of the fact that the diagnosis is relatively easily
made with the help of a structured interview or by filling out an uncomplicated questionnaire.
Discussions of the problem and attendance at special diabetic training courses could
represent a first step in the treatment of such depressions. When a drug therapy for
depression is initiated, attention must be given to possible side effects and/or interactions
with the diabetes therapy.
Key words
Diabetes - depression - diagnosis with structured interviews - drug therapy for depression
Literatur
- 1
Zhang X, Norris SL, Gregg EW, Cheng YJ, Beckles G.
Depressive Symptoms and Mortality among Persons with and without Diabetes.
Am J Epidemiol.
2005;
161
652-660
- 2
Katon WJ, Rutter C, Simon G et al..
The association of comorbid depression with mortality in patients with type 2 diabetes.
Diabetes Care.
2005;
28
2668-2672
- 3
Black SA, Markides KS, Ray LA.
Depression Predicts Increased Incidence of Adverse Health Outcomes in Older Mexican
Americans With Type 2 Diabetes.
Diabetes Care.
2003;
26
2822-2828
- 4
De Groot M, Anderson RJ, Freedland KE, Clouse RE, Lustman PJ.
Association of Depression and Diabetes Complications: A Meta-Analysis.
Psychosom Med.
2001;
63
619-630
- 5
Gonzalez JS, Peyrot M, McCarl LA et al..
Depression and Diabetes Treatment Nonadherence: A Meta-Analysis.
Diabetes Care.
2008;
31
2398-2403
- 6
Goldney RD, Phillips PJ, Fisher LJ, Wilson DH.
Diabetes, depression, and quality of life: a population study.
Diabetes Care.
2004;
27
1066-1070
- 7
Hermanns N, Kulzer B, Krichbaum M, Kubiak T, Haak T.
How to screen for depression and emotional problems in patients with diabetes: comparison
of screening characteristics of depression questionnaires, measurement of diabetes-specific
emotional problems and standard clinical assessment.
Diabetologia.
2006;
49
469-477
- 8
Pan A, Lucas M, Sun Q et al..
Bidirectional association between depression and type 2 diabetes mellitus in women.
Arch Intern Med.
2010;
170
1884-1891
- 9
Rubin RR, Ma Y, Marrero DG et al..
Elevated depression symptoms, antidepressant medicine use, and risk of developing
diabetes during the diabetes prevention program.
Diabetes Care.
2008;
31
420-426
- 10
Kivimaki M, Tabak AG, Lawlor DA et al..
Antidepressant use before and after the diagnosis of type 2 diabetes: a longitudinal
modeling study.
Diabetes Care.
2010;
33
1471-1476
- 11
Nouwen A, Winkley K, Twisk J et al..
Type 2 diabetes mellitus as a risk factor for the onset of depression: a systematic
review and meta-analysis.
Diabetologia.
2010;
53
2480-2486
- 12
Mezuk B, Eaton WW, Albrecht S, Golden SH.
Depression and type 2 diabetes over the lifespan: a meta-analysis.
Diabetes Care.
2008;
31
2383-2390
- 13
Kulzer B.
Diabetes und Depression.
Der Diabetologe.
2008;
4
129-142
- 14
Pickup JC.
Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes.
Diabetes Care.
2004;
27
813-823
- 15
Herpertz S, Petrak F, Albus C et al..
Psychosoziales und Diabetes mellitus. Evidenzbasierte Diabetes-Leitlinien der Deutsche
Diabetes Gesellschaft (DDG) und Deutsches Kollegium Psychosomatische Medizin (DKPM).
Diabetes und Stoffwechsel.
2003;
12
(S 02)
69-94
- 16
Pouwer F, Snoek FJ, Van Der Ploeg HM, Ader HJ, Heine RJ.
Monitoring of psychological well-being in outpatients with diabetes: effects on mood,
HbA(1c), and the patient's evaluation of the quality of diabetes care: a randomized
controlled trial.
Diabetes Care.
2001;
24
1929-1935
- 17
Kulzer B, Hermanns N, Reinecker H, Haak T.
Effects of self-management training in Type 2 diabetes: a randomized, prospective
trial.
Diabetic Medicine.
2007;
24
415-423
- 18 Deutsche Gesellschaft für Psychiatrie PuN .Praxisleitlinien in Psychiatrie und
Psychotherapie: Band 5: Behandlungsleitlinie Affektive Erkrankungen. Darmstadt: Steinkopff;
2000
- 19 DGPPN, BÄK, KBV, AWMF, AkdÄ, BPtK et al.. S3-Leitlinie/Nationale Versorgungs Leitlinie
Unipolare Depression-Langfassung. Available from: http://www.versorgungsleitlinien.de/themen/depression/pdf/s3_nvl_depression_lang.pdf [cited 2011 Apr 21]
- 20 Benkert O, Hippius H. Kompendium der Psychiatrischen Pharmakotherapie. Aufl. Berlin:
Springer; 2007. 6
Korrespondenz
Prof. Dr. Norbert Hermanns
Forschungsinstitut Diabetes Diabetes Zentrum Mergentheim
Theodor-Klotzbücher-Str. 12
97980 Bad Mergentheim
Email: hermanns@diabetes-zentrum.de
